3 documents found, page 1 of 1
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
Hellings, Peter; Alobid, Isam; Anselmo‐Lima, Wilma T.; Bernal‐Sprekelsen, Manuel; Bjermer, Leif; Caulley, Lisa; Chaker, Adam; Constantinidis, JannisFollowing the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) treatment algorithm for chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), patients suffering from severe uncontrolled CRSwNP are recommended to receive oral corticosteroids, (revision) sinus surgery, systemic biologicals and/or aspirin treatment after desensitization (ATAD). Given the major differences in ind...
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W.J.; Lund, V.J.; Hopkins, C.; Hellings, Peter; Kern, R.; Reitsma, S.; Toppila-Salmi, S.; Bernal-Sprekelsen, M.; Mullol, J.; Alobid, I.The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the ei...
EPOS2020: development strategy and goals for the latest European Position Paper...
Fokkens, W; Desrosiers, M; Harvey, R; Hopkins, C; Mullol, J; Philpott, C; Alobid, I; Lima, W T Anselmo; Bachert, Claus; Baroody, F; Bernal-Sprekelsen, MBackground: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clea...